Chen Wei Lin
Impact in
-
- Pharmaceutical Practices and Patient Outcomes
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
-
- Cancer, Hypoxia, and Metabolism 1
- Cancer-related molecular mechanisms research 1
- Co-authors
- Mengting Wang (7 shared papers)Chen‐Liang Tsai (6 shared papers)Yu‐Juei Hsu (5 shared papers)Jun‐Ting Liou (4 shared papers)Chin‐Bin Yeh (3 shared papers)Rita P.‐Y. Chen (4 shared papers)Chi‐Wei Chang (2 shared papers)Pang‐Hsien Tu (2 shared papers)
- Journals
- PLoS ONE (2 papers)Thrombosis and Haemostasis (1 paper)Journal of Alzheimer s Disease (1 paper)Mayo Clinic Proceedings (1 paper)JAMA Psychiatry (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chen Wei Lin
17 papers receiving 422 citations
Peers
Comparison fields: 5 of 68
- Geriatrics and Gerontology 20
- Pulmonary and Respiratory Medicine 136
- Internal Medicine 13
- Physiology 74
- Pharmaceutical Science 20
Countries citing papers authored by Chen Wei Lin
This map shows the geographic impact of Chen Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Wei Lin more than expected).
Fields of papers citing papers by Chen Wei Lin
This network shows the impact of papers produced by Chen Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Wei Lin. The network helps show where Chen Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2017 | 58 | |
| 3 | 2017 | 57 | |
| 4 | 1995 | 32 | |
| 5 | 2021 | 24 | |
| 6 | Aquaporin-8 mediates human esophageal cancer Eca-109 cell migration via the EGFR-Erk1/2 pathway. | 2014 | 22 |
| 7 | 2016 | 22 | |
| 8 | 2016 | 20 | |
| 9 | 2017 | 18 | |
| 10 | 2014 | 16 | |
| 11 | 2018 | 15 | |
| 12 | 2014 | 12 | |
| 13 | 2020 | 10 | |
| 14 | 2015 | 8 | |
| 15 | 2013 | 7 | |
| 16 | 2025 | 3 | |
| 17 | Cloning and Expression Analysis of RAV Gene Related to Cold Stress from Tea Plant [Camellia sinensis (L.) O.Kuntz] | 2010 | 2 |
About Chen Wei Lin
Chen Wei Lin is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Internal Medicine and Geriatrics and Gerontology, having authored 17 papers that have together received 435 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Alzheimer's disease research and treatments (2 papers), Prion Diseases and Protein Misfolding (2 papers), Ion Transport and Channel Regulation (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cancer-related molecular mechanisms research (1 paper), Schizophrenia research and treatment (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Geriatrics and Gerontology (20 citations), Pulmonary and Respiratory Medicine (136 citations), Internal Medicine (13 citations), Physiology (74 citations) and Pharmaceutical Science (20 citations). Chen Wei Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Mengting Wang, Chen‐Liang Tsai, Yu‐Juei Hsu, Jun‐Ting Liou, Chin‐Bin Yeh, Rita P.‐Y. Chen, Chi‐Wei Chang, Pang‐Hsien Tu, Yahan Wang and Ren‐Shyan Liu. Their work appears in journals such as PLoS ONE, Thrombosis and Haemostasis, Journal of Alzheimer s Disease, Mayo Clinic Proceedings and JAMA Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.